NEW YORK (GenomeWeb News) – GE Healthcare said this week it won a tender offer to exclusively provide next-generation sequencing services to a Karolinksa Institutet research group. The first clinical study using the technology will be directed at identifying mutations and genetic variants associated with metastatic breast cancer. Karolinska will provide patient tissue samples for the study. SeqWright Genomics Services, a subsidiary of GE Healthcare, will provide the sequencing services for analysis of the tissue samples.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: The sea anemone is sequenced, a team describes a CRISPR/Cas9-based approach to label specific sites in the genome, and more. 

In a short video, CNN introduces viewers to a fecal transplant poop donor and explains how the treatments are made.

Researchers are testing the use of transgenically altered diamondback moths as an alternative to pesticides in controlling the bugs.

Two recent papers published in Science and Nature Medicine describe work that may result in a universal vaccine for the flu.